Jak 2 Exon 12-15 Mutation Analysis | Accurate Genetic Testing & Results
AED2,720.00
The Jak 2 Exon 12-15 Mutation Analysis is a specialized genetic test designed to detect mutations in exons 12-15 of the JAK2 gene, which are associated with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV) and other hematologic disorders. This test offers high sensitivity and specificity, enabling early and accurate diagnosis, which is crucial for targeted treatment decisions and disease monitoring. Unlike standard JAK2 V617F mutation tests, this analysis identifies rare but clinically significant mutations, providing comprehensive genetic profiling for patients with suspected MPNs. Its advanced molecular technology ensures reliable results, supporting personalized therapeutic strategies and improving patient outcomes.
Description
Jak 2 Exon 12-15 Mutation Analysis
Unlock critical insights into myeloproliferative disorders with the Jak 2 Exon 12-15 Mutation Analysis, a highly specialized genetic test designed to detect mutations in the JAK2 gene, specifically within exons 12 to 15. These mutations are strongly associated with conditions such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), making this test an essential tool for accurate diagnosis and disease classification.
### Key Features:
– Comprehensive Mutation Detection: Identifies key mutations in exons 12-15 of the JAK2 gene, including the well-known V617F mutation in exon 14 and less common exon 12 mutations linked to PV.
– High Sensitivity & Specificity: Utilizes advanced molecular techniques such as PCR and sequencing to ensure precise and reliable results.
–Early & Accurate Diagnosis: Aids in differentiating between various myeloproliferative neoplasms (MPNs), enabling timely and targeted treatment strategies.
– Personalized Treatment Guidance: Supports clinicians in tailoring therapeutic approaches, including JAK inhibitors and other targeted therapies, based on the patient’s genetic profile.
– Fast Turnaround Time: Delivers results promptly, allowing for quicker clinical decision-making and improved patient outcomes.
### Benefits to the Customer:
– Enhanced Diagnostic Confidence: Provides a definitive genetic marker for MPNs, reducing diagnostic uncertainty.
– Optimized Patient Management: Helps hematologists and oncologists refine treatment plans, improving prognosis and quality of life for patients.
– Proactive Disease Monitoring: Enables ongoing assessment of disease progression and response to therapy.
– Cutting-Edge Genetic Insights: Leverages the latest advancements in molecular diagnostics to offer unparalleled accuracy and reliability.
### Who Should Use This Test?
This test is ideal for hematologists, oncologists, and genetic specialists seeking to confirm or rule out JAK2-related myeloproliferative disorders. It is particularly valuable for patients presenting with unexplained erythrocytosis, thrombocytosis, or bone marrow abnormalities suggestive of MPNs.
Empower your clinical decisions with the Jak 2 Exon 12-15 Mutation Analysis—a critical step toward precision medicine in hematology.
Reviews
There are no reviews yet.